Tucson, AZ, United States of America

Deborah Strootman




Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 196(Granted Patents)


Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Deborah Strootman

Introduction

Deborah Strootman is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of medicine, particularly in the treatment of ischemic lesions and diabetic foot ulcers. With a total of 4 patents to her name, her work has the potential to improve the quality of life for many patients suffering from these conditions.

Latest Patents

One of her latest patents focuses on the "Use of treprostinil to treat and prevent ischemic lesions." This patent describes novel methods for using treprostinil or its derivatives for the treatment and prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma, Buerger's disease, and Raynaud's disease. The patent also includes kits for treatment that contain an effective amount of treprostinil or its derivatives.

Another significant patent by Strootman is the "Use of treprostinil to treat neuropathic diabetic foot ulcers." This invention outlines methods for using treprostinil or its derivatives for the treatment and prevention of foot ulcers in subjects with diabetic neuropathy. Similar to her other patent, this one also includes kits for treatment that comprise an effective amount of treprostinil or its derivatives.

Career Highlights

Deborah Strootman is currently associated with United Therapeutics Corporation, where she continues to innovate and develop new treatments. Her work has garnered attention in the medical community, and her patents reflect her commitment to addressing critical health issues.

Collaborations

Throughout her career, Strootman has collaborated with notable colleagues, including Michael Wade and Roger Jeffs. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Deborah Strootman is a trailblazer in the field of medical innovation, with a focus on improving treatments for ischemic lesions and diabetic foot ulcers. Her contributions through her patents are paving the way for better healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…